Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 108, Issue 45, Pages 18488-18493
Publisher
Proceedings of the National Academy of Sciences
Online
2011-10-25
DOI
10.1073/pnas.1104807108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
- (2011) John A. Allen et al. Annual Review of Pharmacology and Toxicology
- Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder
- (2011) Douglas S. Johnson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- The Presynaptic Component of the Serotonergic System is Required for Clozapine's Efficacy
- (2010) Prem N Yadav et al. NEUROPSYCHOPHARMACOLOGY
- Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity
- (2009) Chantal Schlumberger et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structural Determinants of G-protein α Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2)
- (2009) Adam J. Kimple et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
- (2009) A. I. Abbas et al. JOURNAL OF NEUROSCIENCE
- Genetic Deletion of p90 Ribosomal S6 Kinase 2 Alters Patterns of 5-Hydroxytryptamine2A Serotonin Receptor Functional Selectivity
- (2009) R. T. Strachan et al. MOLECULAR PHARMACOLOGY
- Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
- (2009) Ningning Guo et al. NEUROPSYCHOPHARMACOLOGY
- A -Arrestin-Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
- (2009) D. Gesty-Palmer et al. Science Translational Medicine
- Akt/GSK3 Signaling in the Action of Psychotropic Drugs
- (2008) Jean-Martin Beaulieu et al. Annual Review of Pharmacology and Toxicology
- A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
- (2008) Jean-Martin Beaulieu et al. CELL
- Opportunities and Challenges of Psychiatric Drug Discovery: Roles for Scientists in Academic, Industry and Government Settings
- (2008) P Jeffrey Conn et al. NEUROPSYCHOPHARMACOLOGY
- Arresting serotonin
- (2008) A. Abbas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antagonism of dopamine D2 receptor/ -arrestin 2 interaction is a common property of clinically effective antipsychotics
- (2008) B. Masri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started